CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-04 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +33,512 | 207,534 | ||
| 2024-03-04 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −33,512 | 207,534 | ||
| 2024-03-04 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Grant or award · Restricted Share Units | +93,005 | 93,005 | ||
| 2024-03-04 | Weiss Amir Chief Accounting Officer | Option exercise | +10,676 | 29,750 | ||
| 2024-03-04 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −10,676 | 21,355 | ||
| 2024-03-04 | Weiss Amir Chief Accounting Officer | Grant or award · Restricted Share Units | +22,600 | 22,600 | ||
| 2024-03-03 | Conway Vikki L See "Remarks" | Option exercise 10b5-1 | +5,179 | 8,107 | ||
| 2024-03-03 | Conway Vikki L See "Remarks" | Option exercise · Restricted Share Units 10b5-1 | −5,179 | 15,538 | ||
| 2024-03-03 | Francis Richard D President and CEO | Option exercise 10b5-1 | +67,231 | 154,356 | ||
| 2024-03-03 | Francis Richard D President and CEO | Option exercise · Restricted Share Units 10b5-1 | −67,231 | 201,693 | ||
| 2024-03-03 | Drape Eric Executive VP Global Operations | Option exercise 10b5-1 | +24,900 | 44,416 | ||
| 2024-03-03 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units 10b5-1 | −24,900 | 74,701 | ||
| 2024-03-03 | Daniell Richard Exec. VP, European Commercial | Option exercise 10b5-1 | +62,250 | 132,020 | ||
| 2024-03-03 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units 10b5-1 | −62,250 | 186,753 | ||
| 2024-03-03 | Hughes Eric A See "Remarks" | Option exercise 10b5-1 | +24,900 | 24,900 | ||
| 2024-03-03 | Hughes Eric A See "Remarks" | Option exercise · Restricted Share Units 10b5-1 | −24,900 | 74,701 | ||
| 2024-03-03 | Sabag Mark EVP, International Markets | Option exercise | +24,900 | 367,181 | ||
| 2024-03-03 | Sabag Mark EVP, International Markets | Option exercise · Restricted Share Units | −24,900 | 74,701 | ||
| 2024-03-03 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +49,800 | 174,022 | ||
| 2024-03-03 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −49,800 | 174,022 |
Page 24 of 76 · 1,517 trades